chr2-27494639-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022823.3(FNDC4):c.41G>T(p.Arg14Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000415 in 1,445,226 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022823.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FNDC4 | NM_022823.3 | c.41G>T | p.Arg14Leu | missense_variant | 2/7 | ENST00000264703.4 | |
FNDC4 | XM_047445471.1 | c.41G>T | p.Arg14Leu | missense_variant | 1/6 | ||
FNDC4 | XM_005264499.5 | c.41G>T | p.Arg14Leu | missense_variant | 2/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FNDC4 | ENST00000264703.4 | c.41G>T | p.Arg14Leu | missense_variant | 2/7 | 1 | NM_022823.3 | P1 | |
FNDC4 | ENST00000476197.1 | n.174G>T | non_coding_transcript_exon_variant | 1/5 | 2 | ||||
FNDC4 | ENST00000491414.5 | n.350G>T | non_coding_transcript_exon_variant | 2/5 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000447 AC: 1AN: 223786Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 121994
GnomAD4 exome AF: 0.00000415 AC: 6AN: 1445226Hom.: 0 Cov.: 32 AF XY: 0.00000418 AC XY: 3AN XY: 718178
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.41G>T (p.R14L) alteration is located in exon 2 (coding exon 1) of the FNDC4 gene. This alteration results from a G to T substitution at nucleotide position 41, causing the arginine (R) at amino acid position 14 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at